Follow
Emily Lurier
Emily Lurier
Kymera Therapeutics
Verified email at kymeratx.com
Title
Cited by
Cited by
Year
Transcriptome analysis of IL-10-stimulated (M2c) macrophages by next-generation sequencing
EB Lurier, D Dalton, W Dampier, P Raman, S Nassiri, NM Ferraro, ...
Immunobiology 222 (7), 847-856, 2017
1752017
Effect of M1–M2 Polarization on the Motility and Traction Stresses of Primary Human Macrophages
LE Hind, EB Lurier, M Dembo, KL Spiller, DA Hammer
Cellular and molecular bioengineering 9 (3), 455-465, 2016
602016
In Situ Remodeling Overrules Bioinspired Scaffold Architecture of Supramolecular Elastomeric Tissue-Engineered Heart Valves
M Uiterwijk, AIPM Smits, D van Geemen, B van Klarenbosch, S Dekker, ...
JACC: Basic to Translational Science, 2020
562020
Biomaterials and Bioactive Factor Delivery Systems for the Control of Macrophage Activation in Regenerative Medicine
PL Graney, EB Lurier, KL Spiller
ACS Biomaterials Science & Engineering, 0
29
Characterizing the Macrophage Response to Immunomodulatory Biomaterials Through Gene Set Analyses
SE Blatt, EB Lurier, GE Risser, KL Spiller
Tissue Engineering Part C: Methods 26 (3), 156-169, 2020
112020
Nanoparticulate Systems for Controlling Monocyte/Macrophage Behavior
AE Pentecost, EB Lurier, KL Spiller
Microscale Technologies for Cell Engineering, 291-304, 2016
112016
Microscale technologies for cell engineering
AE Pentecost, EB Lurier, KL Spiller, A Singh, AK Gaharwar
Eds. A. Singh, AK Gaharwar, Springer International Publishing, Switzerland …, 2016
102016
Effects of radical oxygen species and antioxidants on macrophage polarization
E Lurier, R Levy, K Barbee, G Golomb, KL Spiller
Biomedical Engineering Conference (NEBEC), 2015 41st Annual Northeast, 1-2, 2015
42015
Heart valve tissue engineering: current preclinical and clinical approaches
L Klouda, EB Lurier, CVC Bouten
Emerging Technologies for Heart Diseases, 383-398, 2020
12020
Evaluating Work Readiness Programs in Merton
EB Lurier, KM Rieger, ME O'Regan, RC Herrera
Worcester Polytechnic Institute, 2013
1*2013
In Vivo Tissue Remodelling Overrules Bioinspired Supramolecular Electrospun Scaffold Architecture in In Situ Heart Valve Tissue Engineering
M Uiterwijk, AIPM Smits, D van Geemen, B van Klarenbosch, S Dekker, ...
JACC: Basic to Translational Science, 2020
2020
Heart Valve Tissue Engineering: Current Preclinical and Clinical approaches
EB Lurier, CVC Bouten
Emerging Technologies for Heart Diseases: Treatments for Heart Failure and …, 2020
2020
Long Term Effect of Scaffold Fiber Orientation on In-Situ Tissue Engineered Heart Valves
M Uiterwijk, A Smits, D van Geemen, B van Klarenbosch, S Dekker, ...
Structural Heart 3 (sup1), 129-129, 2019
2019
Design of an affinity based cytokine release system to temporally control macrophage behavior
E Lurier, A Smits, CVC Bouten, KL Spiller
42nd Society for Biomaterials Annual Meeting and Exposition 2019: The …, 2019
2019
Effects of Scaffold Fiber Orientation on Quality of In-Situ Tissue Engineered Heart Valves
M Uiterwijk, A Smits, D van Geemen, BR van Klarenbosch, S Dekker, ...
Circulation 138 (Suppl_1), A15544-A15544, 2018
2018
Role of IL10-Stimulated" M2c" Macrophages in Early Stages of Wound Healing
EB Lurier, D Dalton, W Dampier, N Ferraro, S Nassiri, P Raman, ...
TISSUE ENGINEERING PART A 22, S27-S28, 2016
2016
Effects of Reactive Oxygen Species and Antioxidants on Macrophage Polarization
EB Lurier, R Levy, K Barbee, G Golomb, KL Spiller
TISSUE ENGINEERING PART A 21, S143-S143, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–17